← Back to Search

Predicting BCG Response

Kyoto, Japan
N/A
Recruiting
Led By Hideki Furuya, PhD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

To date, there are no diagnostics capable of predicting treatment response to intravesical BCG. Because of this severe limitation, nearly 50% of patients treated with BCG fail therapy and will a) require additional intravesical therapy or b) require cystectomy. A urine-based diagnostic that possesses the potential to accurately identify patients who will respond favorably to intravesical BCG is desperately needed.

See full description
Eligible Conditions
  • Bladder Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Closest Location:Cedars-Sinai Medical Center· Los Angeles, CA· 1982 miles
Image of Cedars-Sinai Medical Center in Los Angeles, United States.Image of Cedars-Sinai Medical Center in Los Angeles, United States.Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Who is running the clinical trial?

University of California, Los AngelesOTHER
1,586 Previous Clinical Trials
10,422,226 Total Patients Enrolled
National Cancer Institute (NCI)NIH
14,057 Previous Clinical Trials
41,149,028 Total Patients Enrolled
Nonagen Bioscience CorporationIndustry Sponsor
4 Previous Clinical Trials
1,850 Total Patients Enrolled
University of California, San FranciscoOTHER
2,628 Previous Clinical Trials
19,028,492 Total Patients Enrolled
University of RochesterOTHER
882 Previous Clinical Trials
554,290 Total Patients Enrolled
Kyoto UniversityOTHER
37 Previous Clinical Trials
26,082 Total Patients Enrolled
Cedars-Sinai Medical CenterLead Sponsor
520 Previous Clinical Trials
164,220 Total Patients Enrolled
Hideki Furuya, PhDPrincipal InvestigatorCedars-Sinai Medical Center
2 Previous Clinical Trials
1,200 Total Patients Enrolled
Charles Rosser, MDStudy DirectorNonagen Bioscience Corporation
2 Previous Clinical Trials
1,350 Total Patients Enrolled
Amit Gupta, MDPrincipal InvestigatorCedars-Sinai Medical Center
3 Previous Clinical Trials
47,191 Total Patients Enrolled
~78 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top